ALS Reversals - Lunasin Regimen
NCT02709330
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
ALS (Amyotrophic Lateral Sclerosis)
Interventions
DRUG:
Lunasin Regimen
OTHER:
Historical control
Sponsor
Richard Bedlack, M.D., Ph.D.